SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-335069
Filing Date
2017-11-07
Accepted
2017-11-07 08:01:47
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d440345d10q.htm 10-Q 269309
2 EX-31.1 d440345dex311.htm EX-31.1 9526
3 EX-31.2 d440345dex312.htm EX-31.2 9527
4 EX-32.1 d440345dex321.htm EX-32.1 4770
5 EX-32.2 d440345dex322.htm EX-32.2 4838
  Complete submission text file 0001193125-17-335069.txt   1950354

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20170930.xml EX-101.INS 234406
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20170930.xsd EX-101.SCH 28462
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20170930_cal.xml EX-101.CAL 29299
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20170930_def.xml EX-101.DEF 173604
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20170930_lab.xml EX-101.LAB 239898
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20170930_pre.xml EX-101.PRE 204049
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 171181160
SIC: 2834 Pharmaceutical Preparations